The negative impact of cytomegalovirus (CMV) infection on transplant outcomes warrants
efforts toward improving its prevention, diagnosis, and treatment. During the last 2 decades …

Hepatitis C virus (HCV) infection is a prevalent infection in most developed countries
affecting 1.5–2% of the general population [1]. The natural history of this infection has been …

Background. Antiviral prophylaxis has been shown to decrease the incidence of
cytomegalovirus (CMV) disease in organ transplant recipients, but whether CMV disease …

Cytomegalovirus (CMV) is a common viral pathogen that influences the outcome of liver
transplantation. In addition to the direct effects of CMV syndrome and tissue-invasive …

Hepatitis C virus (HCV) infection represents an important public health problem worldwide.
Reduction of HCV morbidity and mortality is a current challenge owned to several viral and …

Past exposure to hepatitis C virus (HCV) is mostly determined by testing for specific
antibodies using an approved enzyme immunoassay (EIA). The presence of antibody shows …

Cytomegalovirus (CMV) infection remains a major complication of solid organ
transplantation. Because of management of CMV is variable among transplant centers, in …

The variable impact of specific risk factors on survival outcomes based on pre-
transplantation diagnosis was analyzed in adult liver transplant recipients reported to the …

Transplant recipients receiving immunosuppressive therapy are at increased risk of active
cytomegalovirus (CMV) infection and disease. Without appropriate prophylaxis, as many as …

Significant liver fibrosis (F≥ 2) and portal hypertension (hepatic venous pressure gradient
[HVPG]≥ 6 mmHg) at 1 year after liver transplantation (LT) identify patients with severe …